Lymphocyte

Type: Product
Name: Lymphocyte
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Universal blood test for cancer

7 mins ago in Science.Bradford - Scientists have devised a simple blood test that can be used to diagnose whether people have cancer or not. The researchers are heralding it as the first 'universal test for cancer'.The new test has been devised by scientists ... [Published Digital Journal - 6 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Human CD56+ Cytotoxic Lung Lymphocytes Kill Autologous Lung Cells in Chronic Obstructive Pulmonary Disease

by Christine M. Freeman, Valerie R. Stolberg, Sean Crudgington, Fernando J. Martinez, MeiLan K. Han, Stephen W. Chensue, Douglas A. Arenberg, Catherine A. Meldrum, Lisa McCloskey, Jeffrey L. CurtisCD56+ natural killer (NK) and CD56+ T cells, from sputum ... [Published Plosone.org - 7 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy

by Franziska D. Weber, Isabelle Weinhofer, Angelika Einwich, Sonja Forss-Petter, Zahid Muneer, Harald Maier, Willi H. A. Weber, Johannes BergerX-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is a clinically heterogeneous disease ... [Published Plosone.org - 9 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Positive opinion for chronic lymphocytic leukaemia drug

News, July 31 2014.NewsBlogsThe Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on the Marketing Authorisation Application (MAA) for Zydelig (idelalisib 150mg film-coated tablets), a first-in-class treatment for patients ... [Published GM Journal - 11 hours ago]
First reported Jul 30 2014 - Updated 17 hours ago - 3 reports

Blood test could diagnose cancer

Researchers from the University of Bradford  have devised a blood test that could be used to diagnose cancer.The research, published in the FASEB Journal , shows that the method gives a high degree of accuracy diagnosing cancer and pre-cancerous conditions ... [Published Healthcare Learning Company - 17 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Strides receives FDA approval for transplant drug

Strides Arcolab, a developer of pharmaceutical products, over-the-counter products and nutraceuticals, has received the FDA approval for Tacrolimus Capsules USP, 0.5mg, 1mg, and 5mg. Tacrolimus capsule is an immunosuppressant used for preventing organ ... [Published Individual.com - 17 hours ago]
First reported Jul 30 2014 - Updated 19 hours ago - 2 reports

Gilead Sciences receives FDA approval for blood cancer drug

Gilead Sciences, Inc., a biopharmaceutical company, has received the FDA approval for Zydelig 150mg tablets for the treatment of three B-cell blood cancers, relapsed chronic lymphocytic leukemia, follicular lymphoma and small lymphocytic lymphoma. ... [Published Individual.com - 19 hours ago]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

Brown, Dry Plaques: Your Dx?

These asymptomatic plaques developed on the legs of a 59-year-old woman with diabetes mellitus and pulmonary sarcoidosis. Biopsy showed a granulomatous infiltrate of epithelioid histiocytes and multinucleated giant cells surrounded by lymphocytes “layered” ... [Published Consultant Live - 22 hours ago]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Gilead, Janssen-Cilag Cancer Drugs, Allergan Eye Treatment Recommended by EU Advisors

A key European advisory panel gave positive opinions for Gilead’s Zydelig and Janssen-Cilag’s Imbruvica to treat various forms of rare blood cancers and a new indication for Allergan’s Ozurdex to treat the eye disorder diabetic macular edema.The recommendations ... [Published FDA News - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 2 reports

Proctologists Despair: Researchers Devise a Potential Universal Cancer Test

wikimedia I know that, like me, many ofyou look forward to colonscopies every five years, annual prostatemassages, and the singular excitement of esophageal endoscopy asways to check for early signs of cancer. That being the case, it ismy sad duty to ... [Published REASON Online - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

EMA committee recommends approval of Gilead Sciences’ Zydelig

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead Sciences' marketing authorisation application for Zydelig to treat chronic lymphocytic leukaemia (CLL) and follicular ... [Published Pharmaceutical Technology - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Sjogren Syndrome

Medical Treatment Follow-up Web Links Sjögren's syndrome is a disorder of the moisture-producing glands, such as the tear glands (lacrimal glands) and the salivary glands. These glands become infiltrated with white blood cells (lymphocytes) that are part ... [Published eMedicine Health - Jul 30 2014]

Quotes

...different types of cancer and we accept that more research needs to be done; but these results so far are remarkable," said Professor Anderson. "Whilst the numbers of people we tested are, in epidemiological terms, quite small, in molecular epidemiological terms, the results are powerful. We've identified significant differences between the healthy volunteers, suspected cancer patients and confirmed cancer patients of mixed ages at a statistically significant level of P"
...with IMBRUVICA and which indicate a continued strong growth trend for the remainder of the year," said Bob Duggan, Chairman & CEO of Pharmacyclics. "This quarter's results are bolstered by a well executed commercial strategy, availability of compelling clinical data, and a robust presence within scientific peer-review forums. In addition, recent regulatory actions both in the U S and in Europe continue to validate the efficacy, safety and tolerability of IMBRUVICA, and strengthen its brand within the CLL prescriber, patient and payor environments."
"Our study identified common inflammatory mechanisms shared by type 2 diabetes and periodontal disease. It paves the way for the development of novel therapeutics which aim to simultaneously treat both type 2 diabetes and its complications" said Min Zhu, Ph D , a researcher involved in the work from the department of microbiology at Boston University School of Medicine in Boston, Massac...

More Content

All (757) | News (619) | Reports (1) | Blogs (118) | Audio/Video (0) | Fact Sheets (0) | Press Releases (12)
sort by: Date | Relevance
Vaccine for the treatment of Mycobacterium rela... [Published PharmCast - 3 hours ago]
Universal blood test for cancer [Published Digital Journal - 6 hours ago]
Human CD56+ Cytotoxic Lung Lymphocytes Kill Aut... [Published Plosone.org - 7 hours ago]
Pharmacyclics Reports Second Quarter 2014 Results [Published Nasdaq - 7 hours ago]
New products for pharmacists 08-10-2014 [Published Drugtopics.com - 9 hours ago]
Evaluation of Retinoids for Induction of the Re... [Published Plosone.org - 9 hours ago]
GSK and Genmab Announce Positive Interim Result... [Published GlobeNewswire - 10 hours ago]
FDA Advisory Committee Panel Provides Favorable... [Published Investor's Business Daily - 10 hours ago]
FDA Advisory Committee Panel Provides Favorable... [Published Minyanville - 10 hours ago]
Positive opinion for chronic lymphocytic leukae... [Published GM Journal - 11 hours ago]
The Debut of Vedolizumab for Inflammatory Bowel... [Published General Medicine eJournal - 12 hours ago]
Pfizer’s Stake in Cellectis’ Capital is Welcome... [Published MoneyShow.com - 12 hours ago]
Monthly News Roundup - July 2014 [Published Drugs.com - 13 hours ago]
Researchers uncover cause of gum disease relate... [Published EurekAlert! - 15 hours ago]
Blood test could diagnose cancer [Published Healthcare Learning Company - 17 hours ago]
Strides receives FDA approval for transplant drug [Published Individual.com - 17 hours ago]
Gilead Sciences receives FDA approval for blood... [Published Individual.com - 19 hours ago]
Brown, Dry Plaques: Your Dx? [Published Consultant Live - 22 hours ago]
"Anti-Measles Cancer Immunotherapy" in Patent A... [Published HispanicBusiness.com - 23 hours ago]
From Roche's improved anti-CD20 monoclonal anti... [Published Live-PR.com - Jul 31 2014]
Patent Issued for Compositions Including Beta-H... [Published 4 Traders - Jul 31 2014]
B7-H3L cell surface antigen and antibodies that... [Published PharmCast - Jul 31 2014]
"Compositions and Methods for Inducing Immune R... [Published 4 Traders - Jul 31 2014]
U.S. Food and Drug Administration Approves Gile... [Published Wall Street Business Network - Jul 31 2014]
"Cyclosporin Derivatives for Treating Ocular an... [Published HispanicBusiness.com - Jul 31 2014]
CADILA HEALTHCARE : "Stable Pharmaceutical Comp... [Published 4 Traders - Jul 31 2014]
ABBOTT LABORATORIES : Investigators from Abbott... [Published 4 Traders - Jul 31 2014]
Patent Issued for Method of Delivering RNA Inte... [Published HispanicBusiness.com - Jul 31 2014]
Patent Issued for Cloning and Expression of HTL... [Published HispanicBusiness.com - Jul 31 2014]
Imbruvica gains breakthrough status for treatin... [Published Examiner.com - Jul 31 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Proctologists Despair: Researchers Devise a Pot... [Published Hit & Run - Jul 30 2014]
<p><img alt="Colonoscopy" height="225" src="http://cloudfront-assets.reason.com/assets/db/14067391801448.jpg" title="If you're over 50, go get this done. It's no big deal|||wikimedia" width="300" style="float: right;"/&gt;I know that, like me, many o ...
Am I celiac? GF diet does not work for me? [Published HealthBoards - Jul 30 2014]
Hi there,Here is my story.I had a few stressful months with irregular eating in the fall of 2013and I started getting acid reflux, abdominal pain, bloating in generaland constipation in November 2013. I visited regular walk-in clinicwhere they had an ...
Charcot Project: INSPIRE Trial fully recruited [Published Multiple Sclerosis Research - Jul 30 2014]
The INSPIRE Study is now fully recruited. #MSBlog #MSResearch "In response to several requests, I can now confirm that recruitment for the INSPIRE Study is now complete. The study will be closed when the last subject completes 6 months, i.e. early ...
MRI of tumefactive lesions [Published Multiple Sclerosis Research - Jul 29 2014]
Did you present with tumefactive MS? #MSBlog #MSResearch "In recent years I have become interested in the science and philosophy of how we define a disease. This may seem esoteric to you, but it is not and it has many practical implications. For example, ...
Painless “universal” cancer blood test being ex... [Published SlashGear - Jul 28 2014]
A universal blood test that could identify any type of cancer in a patient is one step closer, researchers say, potentially opening the door to diagnosing unusual variations and avoiding expensive and often painful invasive biopsies. Although in its ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Lion Biotechnologies Enters Clinical Trial Gran... [Published GlobeNewswire: Acquisitions News - Jul 30 2014]
Lion Biotechnologies Announces Exclusive Licens... [Published GlobeNewswire: Advertising News - Jul 25 2014]
Lion Biotechnologies Leases New Research Labora... [Published GlobeNewswire: Acquisitions News - Jul 23 2014]
GSK and Genmab announce top-line results from a... [Published GlobeNewswire: Advertising News - Jun 27 2014]
Lion Biotechnologies Appoints Dr. Laszlo Radvan... [Published GlobeNewswire: Advertising News - Jun 23 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.